Fintepla 2.2 mg/ml oral solution clinical trials

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy for Seizures in Patients with Rare Seizure Disorders Such as Epileptic Encephalopathies Including Dravet Syndrome and Lennox-Gastaut Syndrome

This study looks at the long-term safety of Fintepla oral solution for people with rare seizure conditions like Dravet and Lennox-Gastaut syndromes. It checks for side effects and how the body reacts to the medicine over time. It's for adults previously treated with Fintepla.